- Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy. Schiller, J.H., Adak, S., Feins, R.H., Keller, S.M., Fry, W.A., Livingston, R.B., Hammond, M.E., Wolf, B., Sabatini, L., Jett, J., Kohman, L., Johnson, D.H. J. Clin. Oncol. (2001)